MALE GENDER IS ASSOCIATED WITH LARGER PLAQUE VOLUME AT BASELINE AND MORE PLAQUE PROGRESSION AT 12 MONTHS AS ASSESSED BY QUANTITATIVE WHOLE-HEART CORONARY CT ANGIOGRAPHY IN ALL MAJOR EPICARDIAL VESSELS  by Sharma, Abhinav et al.
E725
JACC April 5, 2011
Volume 57, Issue 14
  IMAGING AND DIAGNOSTIC TESTING 
MALE GENDER IS ASSOCIATED WITH LARGER PLAQUE VOLUME AT BASELINE AND MORE PLAQUE 
PROGRESSION AT 12 MONTHS AS ASSESSED BY QUANTITATIVE WHOLE-HEART CORONARY CT 
ANGIOGRAPHY IN ALL MAJOR EPICARDIAL VESSELS
ACC Poster Contributions
Ernest N. Morial Convention Center, Hall F
Sunday, April 03, 2011, 3:30 p.m.-4:45 p.m.
Session Title: CT Coronary Angiography - Plaque Imaging
Abstract Category: 36. CT Coronary Angiography
Session-Poster Board Number: 1061-202
Authors: Abhinav Sharma, Parag H. Joshi, Gustavo Vazquez, Zhen Qian, Torrance Laury, Ambar Bajpai, Sarah Rinehart, Szilard Voros, Piedmont Heart 
Institute, Atlanta, GA
Background:  Progression of coronary atherosclerosis has been studied in isolated lesions with intravascular ultrasound; little is known about 
progression in the entire coronary tree. Contrast-enhanced coronary CTA can quantify plaque in all 3 epicardial coronaries.
Methods:  CTA was performed in 60 symptomatic patients without prior CAD at baseline (60% males, age 60.4±7.2) and was repeated at 1 year 
in 17 patients (64% males, 60.9±6.5). Whole heart plaque volume (PV) was calculated as combined plaque volumes of LM, LAD, LCx, and RCA 
segments greater than 2 mm. Whole heart percent atheroma volume (PAV) was calculated as PV expressed as percentage of the combined vessel 
volumes of these segments. Lipoproteins, PV and PAV were recorded at baseline and one year. Patients were dichotomized as having progressed 
(change in PAV > 3%) or regressed/no change (change in PAV < 3%). Association of baseline characteristics and biomarkers with PV was assessed by 
multiple regression. Significant baseline characteristics and biomarkers in patients with/without progression from univariate analysis were entered 
into a multivariable model.
Results:  Male gender (p < 0.01) was the only independent correlation retained in the multiple regression model of higher PV. When comparing 
those with/without progression (Table), male gender (p < 0.01) remained the only independent predictor of progression multivariable analysis.
Conclusion: Male gender is associated with higher PV and greater risk of progression of PAV by CTA.
Clinical Progressed Regressed p-value
TC (mg/dL) 139.9±27.4 177±46.7 0.05
TG (mg/dL) 128.1±70.4 134.7±63.1 0.85
LDL-C (mg/dL) 74.6±20.8 95.9±38.3 0.16
HDL-C (mg/dL) 31.4±11.2 41.4±9.0 0.05
ApoB (mg/dL) 68.5±13.4 89.3±34.1 0.10
ApoA-I (mg/dL) 120.6±31.0 169.6±32.4 0.01
Age (years) 60.8±7.7 61.1±5.0 0.92
Gender 81.8% Male 18.2% Male 0.03
In Multivariable analysis, male gender was the only significant predictor
